These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8039146)

  • 21. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Data analysis methods and the reliability of analytic epidemiologic research.
    Prentice RL
    Epidemiology; 2008 Nov; 19(6):785-8; discussion 789-93. PubMed ID: 18813015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the epidemiology of human breast cancer.
    Kelsey JL
    Epidemiol Rev; 1979; 1():74-109. PubMed ID: 398270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
    Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
    Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous estrogens and other factors in the epidemiology of breast cancer.
    Kelsey JL; Fischer DB; Holford TR; LiVoisi VA; Mostow ED; Goldenberg IS; White C
    J Natl Cancer Inst; 1981 Aug; 67(2):327-33. PubMed ID: 6943372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.
    Nason FG; Nelson BE
    Obstet Gynecol Clin North Am; 1994 Jun; 21(2):245-70. PubMed ID: 7936544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
    Snedeker SM; Diaugustine RP
    Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of breast cancer. Findings from the nurses' health study.
    Colditz GA
    Cancer; 1993 Feb; 71(4 Suppl):1480-9. PubMed ID: 8431884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship of estrogen and progesterone to breast disease.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):530-8. PubMed ID: 6481706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous hormones and breast cancer risk.
    Bernstein L; Ross RK
    Epidemiol Rev; 1993; 15(1):48-65. PubMed ID: 8405212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental, cellular, and molecular basis of human breast cancer.
    Russo J; Hu YF; Yang X; Russo IH
    J Natl Cancer Inst Monogr; 2000; (27):17-37. PubMed ID: 10963618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms underlying social inequality in post-menopausal breast cancer.
    Hvidtfeldt UA
    Dan Med J; 2014 Oct; 61(10):B4922. PubMed ID: 25283627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progestins and breast cancer: an epidemiologic review.
    Staffa JA; Newschaffer CJ; Jones JK; Miller V
    Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
    Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
    Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.